Stay updated on Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial

Sign up to get notified when there's something new on the Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page footer version indicator was updated from **Revision: v3.5.2** to **Revision: v3.5.3**, reflecting a minor site maintenance/version change without altering the displayed clinical trial study information.
    Difference
    0.0%
    Check dated 2026-04-24T16:53:18.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision: v3.5.2 has been added; Revision: v3.5.0 has been removed.
    Difference
    0.0%
    Check dated 2026-04-17T13:40:57.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.0 (replacing v3.4.3).
    Difference
    0.0%
    Check dated 2026-03-19T23:42:53.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T20:20:57.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    The page shows a revision label update from v3.4.1 to v3.4.2, which does not modify study details or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T01:42:00.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Revision from v3.4.0 to v3.4.1 appears to be a minor site version update with no changes to study data, eligibility criteria, or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T23:30:13.000Z thumbnail image

Stay in the know with updates to Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial page.